Adverse events11

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 11 of 11

Type	Event	Organ system	Group	Affected	At risk	Events
other	Thirst	General disorders	Tolterodine Tartrate	344	9,321	344
other	Constipation	Gastrointestinal disorders	Tolterodine Tartrate	194	9,321	194
other	Dysuria	Renal and urinary disorders	Tolterodine Tartrate	165	9,321	165
serious	Urinary retention	Renal and urinary disorders	Tolterodine Tartrate	4	9,321	4
serious	Intestinal obstruction	Gastrointestinal disorders	Tolterodine Tartrate	2	9,321	2
serious	Pyelonephritis acute	Infections and infestations	Tolterodine Tartrate	1	9,321	1
serious	Dementia	Nervous system disorders	Tolterodine Tartrate	1	9,321	1
serious	Dizziness	Nervous system disorders	Tolterodine Tartrate	1	9,321	1
serious	Vertigo	Ear and labyrinth disorders	Tolterodine Tartrate	1	9,321	1
serious	Rash	Skin and subcutaneous tissue disorders	Tolterodine Tartrate	1	9,321	1
serious	Dysuria	Renal and urinary disorders	Tolterodine Tartrate	1	9,321	1

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01488578/events